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Development of a Packed Bed 
Bioreactor for Cartilage Tissue 
Engineering 
 
Efficient transport of regulatory molecules is one of the main requirements 
for directing the growth and differentiation of bone marrow stromal cells 
(BMSC). We have designed and utilized a packed bed bioreactor system 
for cultivation of murine BMSC immobilized in alginate microbeads 
produced by electrostatic droplet generation. Continuous medium 
perfusion at velocities that are physiological for cartilage and bone (~ 100 
µm/s) provided convective mass transport through the packed bed while 
the small bead diameter (~ 500 µm) ensured short diffusion distances to 
the immobilized cells. Over 5 weeks of cultivation, the cells remained 
viable at a constant density whereas the alginate microbeads retained size 
and spherical shape. Cell density used in this study ( 5 x 106 cells/ml) was 
found to be too low to result in cartilage tissue formation. However, in 
several cases, loosely bonded groups of beads and merged beads without 
visible boundaries were observed, implying that higher cell densities may 
lead to development of a continuous extracellular matrix. This study 
indicates the potentials of the packed bed bioreactor system in conjunction 
with alginate microbeads as cell carriers, for precise regulation of the 
cellular microenvironment in cartilage tissue engineering.  
 





1. INTRODUCTION   
 
Articular hyaline cartilage is an avascular tissue 
containing only one cell type, the chondrocyte, which 
generates and maintains the extracellular matrix (EMC) 
consisting of a fibrous network of collagen type II and 
glycosaminoglycan (GAG)  rich proteoglycans. The 
main function of articular cartilage is to allow joint 
mobility while transferring compressive and shear 
forces. Hyaline cartilage has a very limited capacity for 
intrinsic functional repair. Small chondral defects have 
been reported to regenerate by cell migration but 
untreated, large, full  thickness defects heal with 
formation of fibrocartilaginous repair tissue. This tissue 
significantly differs in composition from the normal 
cartilage resulting in inferior biomechanical function 
and progression to osteoarthritis with an eventual need 
for a total knee replacement surgery [1]. 
Surgical and biological attempts have been made to 
induce significant and durable repair response in 
cartilage defects. The main objectives are symptom 
relief and the reestablishment of normal load  bearing 
function of the articular surface. Current therapies for 
cartilage replacement include allografts and artificial 
plastic and metal implants, which suffer from problems 
such as lack of available donor tissue, rejection, 
increased susceptibility to infection and toxicity. Other 
treatment techniques focus on attempts to recruit 
progenitor cells from the bone marrow by penetration of 
the subchondral bone or transplantation of 
osteochondral grafts, periosteum or perichondrium. 
However, all of these therapies promote formation of a 
fibrous repair tissue showing acceptable shortterm 
results but longterm outcomes are usually unfavorable 
[2, 3].  
Tissue engineering is one of the new strategies that 
have emerged over the past decade to address the 
clinical problem of tissue failure [4, 5, 6]. It is 
particularly significant because it can provide biological 
substitutes of compromised native tissues. Also, 
engineered tissues can serve as physiologically relevant 
models for controlled studies of cells and tissues under 
normal and pathological conditions [7, 8]. Tissue 
engineering combines cells with biomaterials, synthetic 
or natural, and environmental factors to induce 
differentiation signals into surgically transplantable 
formats and promote tissue repair and/or functional 
restoration [6, 7]. Despite many advances, researchers in 
this field still face significant challenges in repairing, 
replacing or regenerating specific tissues or organs. 
Cartilage tissue engineering based on the integrated 
use of chondrogenic cells, biodegradable scaffolds, and 
bioreactors was proposed for in vitro regeneration of 
tissue equivalents that would ideally have site- and 
scale-specific structural and biomechanical properties of 
native articular cartilage, and integrate firmly and 
completely to the adjacent host tissues [6, 7].  
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Cells used in this approach are chondrocytes, fully 
differentiated cells, or osteochondral progenitor cells 
isolated from bone marrow (herein referred to as bone 
marrow stromal cells  BMSC). When selecting the 
optimal cell type to use, one must consider the 
proliferative capacity of the cells ex vivo, phenotypic 
stability, and immunogenicity. The proliferative 
capacity of fully differentiated cartilage adult cells is 
limited and long  term in vitro expansion can reduce 
their functional quality. The other limitation is the 
amount of tissue that can be harvested as well as donor 
site morbidity. On the other hand, BMSC are potential 
cell source with the excellent proliferative and 
regenerative capacity. However, compared to cultures of 
differentiated chondrocytes these cells require 
additional biochemical regulatory signals to induce 
chondrogenic differentiation. The process of stem cell 
chondrogenesis is directed by a number of growth 
factors and signaling molecules in addition to cell  cell, 
and cell  matrix interactions and biomechanical factors. 
Efficient and controlled delivery of biochemical signals 
is thus one of the main requirements in cultures of 
BMSCs. Today the challenge still lies in designing a 
microenvironment to provide the correct instructions to 
bring those cells to the desired functional state to create 
structurally organized cartilage [8, 9]. 
Biomaterials in different forms are used to provide 
three  dimensional support for cells to reside, 
proliferate and produce matrix. The cell support has to 
be porous to allow for effective transport of nutrients 
and waste products as well as biocompatible with the 
host tissue. It should be also biodegradable by 
hydrolytic or enzymatic mechanisms, leaving non-toxic 
degradation products that can be eliminated from the 
body. In addition, the biomaterial support must have the 
appropriate physical and mechanical properties for the 
given application, so to withstand physiologic loading 
until sufficient tissue is regenerated [8, 9].  
Hydrogels are a class of biomaterials that have been 
used widely in the tissue engineering and drug delivery 
fields. A hydrogel is composed of highly crosslinked 
hydrophilic polymer chains to yield a highly swollen, 
water insoluble gel structure. Such environment has 
been shown to support chondrocyte survival and 
cartilage matrix synthesis [9]. The hydrophilicity of 
hydrogels prevents protein adsorption thereby 
minimizing foreign body responses when implanted in 
vivo; but this property also reduces the ability of the 
hydrogel to exert a biological influence onto anchorage 
dependent cells [9] Alginate is one of the most 
important scaffold materials since when crosslinked 
with calcium ions, it forms a gel that is biocompatible, 
biodegradable, and it is easily processed into different 
shapes. When immobilized in alginate matrix 
chondrocytes were shown to retain their phenotype and 
produce cartilaginous components [9, 10, 11] In 
addition, bone marrow cells were shown to proliferate 
and express chondrogenic differentiation when 
entrapped and cultivated in highly pure alginates [13].  
Bioreactors for cartilage tissue engineering should 
maintain controlled conditions in culture medium (e.g., 
temperature, pH, osmolality, levels of oxygen, nutrients, 
metabolites, regulatory molecules), facilitate mass 
transfer, and provide physiologically relevant physical 
signals (e.g., interstitial fluid flow, shear, pressure, 
compression) [7]. Interstitial fluid flow was particularly 
proposed for enhancement of mass transfer directly to 
the cells so that cartridges with porous scaffolds 
perfused by the medium were used for tissue 
engineering of myocardium [14, 15], cartilage 
[16, 17, 18] and bone [19, 20]. 
The goal of this study was to develop a bioreactor 
system with interstitial medium flow coupled with 
alginate as a cell support for cartilage tissue 
engineering. We have previously shown that murine 
BMSC could be effectively immobilized in alginate 
microbeads produced by electrostatic droplet generation 
[21, 22]. In the present work, we have developed a 
packed bed bioreactor for cultivation of BMSC 
immobilized in alginate microbeads under continuous 
perfusion of the culture medium. 
 
2. MATERIALS AND METHODS  
 
2.1 Cell isolation and expansion 
 
Inbred CBA mice, 8  10 weeks old, were used as 
donors of bone marrow cells, which were propagated in 
vitro [22]. Pooled femoral bone marrow cell 
suspensions were prepared in Dulbecco.s Modified 
Eagle Medium (DMEM), centrifuged for 10 min at 
1200 rpm and re  suspended in expansion medium, i.e. 
DMEM supplemented with 10% Fetal Bovine Serum, 
100 U/ml penicillin, 100 µg/ml streptomycin, 0, 1 mM 
non-essential amino acids, - all from Sigma (St. Luis, 
MO) and 1 ng/ml bFGF (human recombinant, R&D 
Systems, Minneapolis, MN). Cells were plated in 25 
cm2 culture flasks at 2 - 4 x 106 cells/ml in 6 ml of 
expansion medium and cultured in a humidified 5% 
CO2 incubator at 37oC. After 3 days, 3 ml of expansion 
medium was added to each flask and thereafter every 3 
days the medium was completely replaced. BMSCs 
were selected based on their ability to adhere to the 
tissue culture plastic and at about 80 % confluence 
(approximately after 7  10 days of culture) the cells 
were detached by using 0.25% trypsin/1 mM EDTA and 
then replated at 16  26 x 103 cells/cm2. Second 
passage BMSCs were cultured in the same manner, and 
harvested at about 80  90% confluence (approximately 
11 days). 
 
2.2 Production of alginate microbeads with 
immobilized cells  
 
Sodium alginate powder (Sigma, St. Luis, MO) was 
dissolved in WFI water at a concentration of 2.2 % w/w 
and then mixed with a suspension of BMSCs in culture 
medium to obtain final concentrations of 1.5 %w/w 
alginate and 5 x 106 cells/ml. Alginate microbeads were 
produced by electrostatic droplet generation [21,22]. In 
brief, cell/alginate suspension was extruded through a 
positively charged blunt stainless steel needle (24 
gauge, 6,4 kV applied potential) at a constant flow rate 
of 14,0 ml/h by a syringe pump and resulting droplets 
were collected in a gelling bath (1.5% w/v CaCl2), as 
shown in the Figure 1. As Na ions were exchanged with 
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Ca ions, alginate droplets hardened and formed 
insoluble microbeads with entrapped cells. The 
microbeads were left for 30 min in the gelling bath in 
order to complete gellation and then were transferred 
into the bioreactor. 
 
 
Figure 1. Experimental set-up for electrostatic generation 
of alginate microbeads with entrapped BMSC 
 
2.3 Bioreactor cultivation 
 
The packed bed bioreactor was custom made at the 
Faculty of Technology and Metallurgy, Belgrade. It 
consisted of two glass halves, which were fit into a 
piece of silicone tubing to form a chamber of 1 ml in 
volume (Figure 2). At the ends of glass halves were 
sintered glass plates, which provided retainment of the 
microbeads in the chamber. The silicone tubing enabled 
continuous gas exchange.  
 
 
Figure 2. Packed bed bioreactor: two glass halves with 
sintered glass plates at the ends were fit into a piece of 
silicone tubing to form a chamber for cultivation of alginate 
microbeads (scale bar 100 µm) 
The packed bed bioreactor was connected to a 
peristaltic pump and a medium reservoir using silicone 
tubing that ensured gas exchange in the culture medium 
(Figure 3). Two syringes were used for medium 
exchange and debubbling. Bioreactor system was placed 
in a humidified 5% CO2 incubator at 37oC.  
Alginate microbeads (1 ml; 5 × 106 cells/ml) were 
placed in the bioreactor chamber and the system was 
filled with 12 ml of the culture medium. Medium for 
cultivation was DMEM supplemented with 10% Fetal 
Bovine Serum, 100 U/ml penicillin, 100 µg/ml 
streptomycin, 50 µg/ml vitamin C, 10 nM dexa-
methasone, and 10 ng/ml TGF-β1 (R&D Systems, 
Minneapolis, MN). Perfusion rate in the system was set 
to 0.18 ml/min. During the 5 weeks of cultivation, 40% 
of medium was exchanged twice a week.  
 
Figure 3. Bioreactor system: the packed bed bioreactor is 
connected to a recirculation loop consisting of a medium 
reservoir and silicone tubing coild for gas exchange. 
 
2.4 Alginate microbead characterization 
 
Diameters of microbeads were measured with an 
accuracy of 10 µm using an optical microscope. The 
average microbead diameter and standard deviations 
were then calculated from the measured data of 20  30 
microbeads. Cell concentrations and viabilities were 
determined following dissolution of microbeads in 
0.05M Na citrate (1g of microbeads in 5 ml of Na-
citrate solution). BMSC cell concentration was 
estimated by using a Thoma counting chamber and cell 
viability was assessed by means of trypan blue staining 
technique.  
Alginate microbeads sampled for histology were 
fixed in 2.5 % glutaraldehide, embedded in araldite, 
cross-sectioned (1.5 µm) by LKB III Ultramicrotom and 
stained with safranin-O and toluidine blue.  
 
3. RESULTS  
 
Electrostatic extrusion resulted in spherical alginate 
microbeads of about 500 µm in diameter with cell 
concentration of 5 × 106 cells/ml. Over 5 weeks of 
cultivation in the packed bed bioreactor, the microbeads 
maintained consistency and spherical shape. 
Immobilized cells remained viable at approximately 
constant concentration showing no significant 
proliferation during the cultivation period. Most of the 
alginate microbeads remained separated and only 
occasionally loosely bonded groups of microbeads were 
observed (Figure 4). These bonds were probably formed 
by secretion of cells at the bead surfaces, noticed in 
several cases (Figure 5). Some of the microbeads 
appeared void of cells (Figure 4) probably due to a 
lower initial cell concentration in these beads. In very 
rare cases, merged microbeads without visible 
boundaries between them were observed (Figure 6).  
Histological staining has shown groups of viable 
cells resembling chondrocytes in lacunae (Figure 7). 
Safranin  O stained non  specific to alginate matrix. 
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Figure 4. Loosely bonded group of microbeads. Sporadic 
beads void of cells could be observed. 
 
Figure 5. Cells at the microbead surface 
 
Figue 6. In very rare cases merged microbeads were 
observed 
 
Figure 7. Histological section of an alginate microbead 
cultured for 5 weeks in the packed bed bioreactor (toluidine 
blue staining) 
4. DISCUSSION  
 
Efficient mass transfer of regulatory molecules is 
one of the most important requirements in cultures of 
BMSC in order to induce desired lineage of 
differentiation. Bioreactors with medium perfusion 
through porous scaffolds seeded with cells were 
proposed for creation of convective mass transport 
through the cultivated tissue. However, in this 
bioreactor design, very low medium velocities are 
required since the cells are directly exposed to the fluid 
flow. Packed bed bioreactor design with cells entrapped 
in alginate particles, on the other hand, can be beneficial 
for providing protection of cells from fluid flow and 
shear stresses. However, this bioreactor design imposes 
a requirement to use small diameter alginate particles (< 
1mm) in order to provide short diffusion distances. In 
this study, we have investigated potential application of 
a packed bed bioreactor with alginate microbeads as 
support for BMSC for cartilage tissue engineering. 
Alginate microbeads were produced by the 
electrostatic droplet generation technique, which was 
shown previously to provide controlled production of 
microbeads down to 50 µm in diameter [23,24]. 
Electrostatic extrusion of BMSC suspension had little 
effect on the cell viability and BMSC entrapped in 
alginate microbeads remained viable for 4 weeks in a 
static culture [22]. In the present study, we have 
cultivated alginate microbeads in a packed bed 
bioreactor with medium perfusion, which provided 
more efficient mass transfer to the beads. Perfusion rate 
was about 100 µm/s, which corresponded to the range 
of blood velocities found in capillaries. In this 
experimental set-up, the cells would ideally regenerate 
cartilaginous matrix leaving the channels mimicking a 
capillary network. In the present study, bonds between 
alginate microbeads and merged microbeads were 
observed only sporadically, which was probably due to 
a generally low initial concentration of cells used. Cell 
density was shown to strongly affect the rate of ECM 
deposition in alginate immobilized chondrocytes such 
that wet weight fractions of GAG and collagen were 
more that 3 fold higher in constructs with initial cell 
density of 64 x 106 cell/ml as compared to the constructs 
initially seeded with 4 x 106 cell/ml [12]. In addition, 
microbeads void of cells observed in the present study 
correspond to findings that biodegradable fibrous 
scaffolds seeded with chondrocytes at low densities 
collapsed after 12 days in culture and confirm the 
hypothesis that there is a minimal cell concentration 
required for cell survival and ECM synthesis [25]. 
However, merged microbeads observed occasionally in 
the present study, imply that higher cell concentrations 
could result in formation of a continuous ECM 
integrating neighboring beads.  
Finally, the system based on alginate microbeads 
and the packed bed bioreactor could have an additional 
potential for cartilage tissue engineering by 
incorporation of encapsulation and controlled delivery 
of regulatory molecules in the vicinity of the 
immobilized BMSC. Alginate matrix itself could be 
used to retain specific biologically active molecules [26] 
or it could incorporate a second delivery system 
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following the approach used in hydrogel systems with 
immobilized chondrocytes and microparticles with 
encapsulated TGF-β1, which were shown to stimulate 
ECM deposition under in vitro conditions [27,28]. 
Interstitial medium flow and controlled delivery of 
regulatory molecules in such system could provide 
precise regulation of the cellular microenvironment 
needed for BMSC cultures. 
 
5. CONCLUSION  
 
In this study, we have utilized a packed bed 
bioreactor system with continuous perfusion of the 
culture medium for in vitro cultivation of murine BMSC 
immobilized in alginate microbeads produced by 
electrostatic droplet generation. Perfusion rate was set to 
physiological blood velocities while the small bead 
diameter (~ 500 µm) provided short diffusion distances. 
Over 5 weeks of cultivation, cells remained viable at a 
constant cell density in preserved alginate microbeads, 
which were sporadically found to form loosely bonded 
groups. Only in very rare cases, merged microbeads 
without visible boundaries were found. However, the 
obtained results imply that the cell density used in this 
study was too low and that higher cell densities may 
lead to formation of a continuous ECM in this system. 
The present work indicates potentials of the packed bed 
bioreactor system in conjunction with alginate 
microbeads for efficient delivery of regulatory 
molecules to the immobilized cells and precise control 
of the cellular microenvironment in cartilage tissue 
engineering. 
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РАЗВОЈ БИОРЕАКТОРСКОГ СИСТЕМА СА 
ПАКОВАНИМ СЛОЈЕМ ЗА ПРИМЕНУ У 
ИНЖЕЊЕРСТВУ ТКИВА ХРСКАВИЦЕ 
 
Андреа Осмокровић, Бојана Обрадовић, Диана 
Бугарски, Бранко Бугарски, Гордана Вуњак-
Новаковић  
 
Ефикасан пренос регулаторних молекула је један од 
основних захтева у културама ћелија костне сржи 
ради подстицаја ћелија на диференцијацију у 
жељеном правцу. У овом раду је развијен и 
примењен биореакторски систем са пакованим 
слојем за култивацију ћелија костне сржи миша 
имобилисаних у алгинатне микрочестице 
произведене техником електростатичке екструзије. 
Континуалним протоком медијума при 
физиолошким брзинама струјања (~ 100 µm/s) 
обезбеђен је конвективни пренос масе у пакованом 
слоју док су малим пречником честица (~ 500 µm) 
остварена мала растојања за дифузиони пренос масе 
до имобилисаних ћелија. У току 5 недеља 
култивације, ћелије су остале вијабилне при 
константној ћелијској густини док су алгинатне 
микрочестице задржале величину и сферичан облик. 
Показало се да је концентрација ћелија коришћена у 
овом раду (5 x 106 ćеl/ml) сувише ниска за 
формирање ткива хрскавице. Међутим, у неколико 
случајева нађене су слабо везане групе 
микрочестица, а понегде и потпуно стопљене 
микрочестица без приметних граница што наводи на 
претпоставку да би при вишим концентрацијама 
ћелија био могућ развој континуалног 
екстрацелуларног матрикса. Резултати добијени у 
овом раду указују на могућност примене 
биореакторског система са пакованим слојем 
алгинатних микрочестица, носача ћелија, за 
прецизну регулацију микро-околине ћелија у 
инжењерству ткива хрскавице. 
 
